Editorials

Emergency contraception

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7008.762 (Published 23 September 1995) Cite this as: BMJ 1995;311:762
  1. Jeanette Cayley
  1. Senior clinical medical officer Women's Services, Featherstone Road Clinic, Southall UB2 5BQ

    Time to loosen medical controls over its availability

    Emergency hormonal contraception is well established in the form of the Yuzpe regimen.1 This comprises 100 μg ethinyloestradiol and 1 mg levonorgestrel given in two doses 12 hours apart. The first dose must be given within 72 hours of the unprotected intercourse or failure of contraception. At present only one medicinal product (PC4) is licensed for the purpose (although an alternative is four tablets of the combined oral contraceptive ethinyloestradiol 50 μg and levonorgestrel 250 μg (Ovran)), and may be obtained only on prescription from general practitioners, family planning clinics, and some accident and emergency departments. But a growing number of doctors would like emergency contraception to be made more widely available, recognising that …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe